Drugmaker Endo Cleared to Poll Creditors on Opioid Settlements

Drug manufacturer Endo International Plc won bankruptcy court permission to poll its creditors on a plan that would hand control of the business to lenders and settle opioid liabilities in deals valued at more than $600 million.

Judge James L. Garrity Jr. said during a Tuesday court hearing in New York he’ll allow Endo creditors to vote on its restructuring plan weeks after the company announced opioid-related settlements.

The judge’s approval keeps Endo on pace to emerge from Chapter 11 protection in the second quarter of 2024. Endo filed for bankruptcy in August 2022 to deal with more than $8 ...